EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 167 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $945,723 | +134.5% | 138,669 | -13.0% | 0.00% | – |
Q1 2024 | $403,335 | +4.7% | 159,421 | -0.7% | 0.00% | – |
Q4 2023 | $385,116 | +366.9% | 160,465 | +561.4% | 0.00% | – |
Q3 2023 | $82,484 | -95.8% | 24,260 | -90.9% | 0.00% | -100.0% |
Q2 2023 | $1,949,690 | -32.4% | 265,264 | -4.7% | 0.00% | -50.0% |
Q1 2023 | $2,885,115 | -10.6% | 278,486 | +1.9% | 0.00% | 0.0% |
Q4 2022 | $3,227,803 | -61.4% | 273,311 | -31.4% | 0.00% | -60.0% |
Q3 2022 | $8,367,000 | -33.2% | 398,593 | -1.2% | 0.01% | -28.6% |
Q2 2022 | $12,525,000 | -19.9% | 403,528 | +5.9% | 0.01% | 0.0% |
Q1 2022 | $15,643,000 | +161.0% | 381,000 | +176.3% | 0.01% | +133.3% |
Q4 2021 | $5,994,000 | -9.6% | 137,885 | +4.2% | 0.00% | 0.0% |
Q3 2021 | $6,629,000 | -21.0% | 132,384 | -0.6% | 0.00% | -25.0% |
Q2 2021 | $8,388,000 | -52.6% | 133,169 | -30.1% | 0.00% | -60.0% |
Q1 2021 | $17,709,000 | -17.1% | 190,604 | -20.0% | 0.01% | -23.1% |
Q4 2020 | $21,359,000 | +12.6% | 238,392 | +29.8% | 0.01% | 0.0% |
Q3 2020 | $18,975,000 | +11.2% | 183,633 | -14.9% | 0.01% | 0.0% |
Q2 2020 | $17,061,000 | +30.3% | 215,734 | -4.7% | 0.01% | +8.3% |
Q1 2020 | $13,095,000 | -3.1% | 226,335 | -9.7% | 0.01% | +33.3% |
Q4 2019 | $13,514,000 | +42.6% | 250,520 | +38.1% | 0.01% | +28.6% |
Q3 2019 | $9,480,000 | +64.7% | 181,377 | +52.1% | 0.01% | +133.3% |
Q2 2019 | $5,757,000 | -54.7% | 119,239 | -52.7% | 0.00% | -62.5% |
Q1 2019 | $12,722,000 | +116.9% | 251,888 | +154.5% | 0.01% | +100.0% |
Q4 2018 | $5,865,000 | -79.1% | 98,974 | -76.8% | 0.00% | -50.0% |
Q3 2018 | $28,104,000 | +10.7% | 426,960 | -15.1% | 0.01% | +14.3% |
Q2 2018 | $25,390,000 | +31.9% | 502,914 | +37.6% | 0.01% | -22.2% |
Q1 2018 | $19,247,000 | +63.1% | 365,607 | +43.9% | 0.01% | +12.5% |
Q4 2017 | $11,800,000 | +70.1% | 254,001 | +48.1% | 0.01% | +60.0% |
Q3 2017 | $6,936,000 | +185.2% | 171,547 | +139.0% | 0.01% | +150.0% |
Q2 2017 | $2,432,000 | +78.0% | 71,773 | +52.4% | 0.00% | +100.0% |
Q1 2017 | $1,366,000 | -16.4% | 47,094 | -5.5% | 0.00% | 0.0% |
Q4 2016 | $1,634,000 | -61.6% | 49,810 | -63.1% | 0.00% | -66.7% |
Q3 2016 | $4,256,000 | +26.9% | 135,054 | +13.1% | 0.00% | +50.0% |
Q2 2016 | $3,355,000 | -19.7% | 119,410 | +3.9% | 0.00% | -33.3% |
Q1 2016 | $4,176,000 | -59.7% | 114,951 | -55.6% | 0.00% | -57.1% |
Q4 2015 | $10,364,000 | +123.0% | 259,110 | +58.8% | 0.01% | +75.0% |
Q3 2015 | $4,647,000 | +18.6% | 163,190 | +37.2% | 0.00% | +33.3% |
Q2 2015 | $3,918,000 | +41.2% | 118,955 | +23.2% | 0.00% | +50.0% |
Q1 2015 | $2,775,000 | +20.9% | 96,555 | +14.5% | 0.00% | +100.0% |
Q4 2014 | $2,295,000 | +71.0% | 84,322 | +33.8% | 0.00% | 0.0% |
Q3 2014 | $1,342,000 | +23.3% | 63,041 | +30.0% | 0.00% | 0.0% |
Q2 2014 | $1,088,000 | -57.0% | 48,511 | -51.6% | 0.00% | -50.0% |
Q1 2014 | $2,533,000 | +14.7% | 100,310 | +4.3% | 0.00% | 0.0% |
Q4 2013 | $2,208,000 | -6.0% | 96,152 | -22.1% | 0.00% | 0.0% |
Q3 2013 | $2,350,000 | – | 123,488 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 1,810,519 | $52,071,000 | 4.06% |
Avoro Capital Advisors LLC | 330,635 | $9,509,000 | 3.65% |
FIDUCIARY MANAGEMENT ASSOCIATES LLC | 766,424 | $22,043,000 | 1.32% |
GREAT POINT PARTNERS LLC | 102,791 | $2,956,000 | 1.30% |
Matarin Capital Management, LLC | 75,380 | $2,167,929,000 | 0.66% |
GLOBEFLEX CAPITAL L P | 89,151 | $2,564,000 | 0.49% |
LaSalle Street Capital Management, LLC | 15,897 | $457,000 | 0.45% |
TFS CAPITAL LLC | 149,318 | $4,294,000 | 0.42% |
TURNER INVESTMENTS LLC | 71,880 | $2,067,000 | 0.37% |
NEW AMSTERDAM PARTNERS LLC/NY | 136,116 | $3,915,000 | 0.32% |